Skip to content
healthcare.dev
Get a free key

ROFLUMILAST

NDC 59651-275, ROFLUMILAST, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-275
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213298
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-275 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST500 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
59651-275-305965102753030 TABLET in 1 BOTTLE (59651-275-30)
59651-275-905965102759090 TABLET in 1 BOTTLE (59651-275-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7cb11d48-6bb9-437b-bc7f-382050a2d3e6

  • NADAC price for package 59651027530

    GET /v1/drugs/nadac/59651027530

  • NADAC price for package 59651027590

    GET /v1/drugs/nadac/59651027590

Use it

Look up 59651-275 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-275 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-275. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.